Key research from the conference highlights opioid addiction research.
A series of research presented at SfN’s Neuroscience 2017 has shed more light on the mechanism by which stress negatively impacts the brain, potentially highlighting future therapeutics.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
Discover the potential advantages of combining imaging and pharmacogenetics approaches in order to better describe the underlying mechanisms of antidepressant response and how this approach could be applied to future studies in this editorial from Pharmacogenomics.
Listen to our latest NCTalks podcast with leading neurosurgeon, Ali Rezai, to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade.
Results from the 60-year Stirling County State Study have reported depression remains strongly associated with a higher risk of early death in men and women, despite increased awareness of mental illness, with this risk increasing for women in recent years.
Overturning previous thoughts on the disease’s localized disruptive effect on the brain; a new study has revealed a significantly larger scope of communications disruption caused by schizophrenia.
Genetic variant relating to protein involved in neurotransmission may affect brain’s ability to regulate emotion.
A new study has shown that individuals with schizophrenia are dying earlier and at a higher rate than those without schizophrenia.